Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Nadofaragene firadenovec intravesical gene therapy continues to show promise in treating BCG-unresponsive NMIBC bladder cancer.

ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...

A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

Providing well-tolerated, preventive TB treatment can reduce the risk of developing active TB disease by 85 per cent in the ...

The United Nations International Children’s Emergency Fund (Unicef) has warned that funding cuts from donor countries will ...

In a landmark humanitarian initiative, the United Arab Emirates (UAE) has unveiled a transformative project to establish ten ...

A dividend from immunisation is a future free from the diseases that rob communities of health and well-being, a future free ...